Prophylactic atropine administration attenuates the prolongation induction time of prior administration of remifentanil.
Not Applicable
Recruiting
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0003179
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
1) adult patients of American Society of Anaesthesiologists physical status class I and II (19-75 years)
2) Patients undergoing general anesthesia and undergoing arterial blood pressure monitoring
Exclusion Criteria
1) Children (under 19 years old)
2) BMI> 30 kg / m 2 or <18.5 kg / m 2
3) Neuromuscular disease or mental illness
4) patients with Metabolic disease
5 )Patients who are expected to have a difficile airway.
6) Patients diagnosed with asthma or Chronic obstructive pulmonary disease
7) Patients with Cardiovascular disease (including hypertension)
8) Patients with renal disease
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method induction time
- Secondary Outcome Measures
Name Time Method Time difference between loss of consciousness;Changes in vital sign and BIS within induction period